1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 Pellegrini, M. Liehr, S. Fisher, A.L. Cooperman, B.S. Mierke, D.F. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic 1 90.00 90.00 90.00 1.000 1.000 1.000 C2 H4 O 44.053 ACETYL GROUP non-polymer C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking US Biochemistry BICHAW 0033 0006-2960 39 12210 12215 10.1021/bi001323a 11015199 Structure-based optimization of peptide inhibitors of mammalian ribonucleotide reductase. 2000 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 940.028 SYNTHETIC CYCLIC PEPTIDE 1 syn polymer no yes (ACE)FELDKDF XFELDKDF A polypeptide(L) n n n n n n n n repository Initial release Version format compliance Atomic model Database references Derived calculations Non-polymer description Structure summary Version format compliance 1 0 2000-11-22 1 1 2008-04-27 1 2 2011-07-13 RCSB Y RCSB 2000-08-29 REL The peptide was synthesized by solid phase synthesis. sample back calculated data agree with experimental NOESY spectrum 100 3 ACE 1 n 1 ACE 1 A PHE 2 n 2 PHE 2 A GLU 3 n 3 GLU 3 A LEU 4 n 4 LEU 4 A ASP 5 n 5 ASP 5 A LYS 6 n 6 LYS 6 A ASP 7 n 7 ASP 7 A PHE 8 n 8 PHE 8 A author_defined_assembly 1 monomeric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 1 A GLU 3 71.91 54.38 1 A ASP 5 158.67 76.52 2 A GLU 3 72.31 53.44 2 A ASP 5 160.37 75.62 3 A ASP 5 159.10 79.50 CYCLIC PEPTIDE INHIBITOR STRUCTURE OF CYCLIC PEPTIDE INHIBITORS OF MAMMALIAN RIBONUCLEOTIDE REDUCTASE 1 N N covale 1.343 A GLU 3 A CD GLU 3 1_555 A LYS 6 A NZ LYS 6 1_555 covale 1.335 A ACE 1 A C ACE 1 1_555 A PHE 2 A N PHE 2 1_555 OXIDOREDUCTASE INHIBITOR transferred NOEs, IRMA refinement, ribonucleotide reductase inhibitors, OXIDOREDUCTASE INHIBITOR 1FOZ PDB 1 1FOZ 1 8 1FOZ 1 8 1FOZ A 1 1 8 1 P 1